OGAB
Dead / Abandoned — Abandoned — failure to respond (as of 02 Mar 2021)
What this means for you
This application is over — abandoned 18 Feb 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79272216
- Mark type
- Stylized text
- Filed
- 22 Aug 2019
- Abandoned
- 18 Feb 2021
- Attorney of record
- Rebeccah Gan
Goods and services
- Class 042 — Scientific and technological services: Research and development relating to DNA synthesis technology; technical advisory services and information technology consulting services relating to DNA synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the fields of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, quality control for others, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells; structural and functional analysis of the genome with genome synthesis technology; DNA screening for scientific research purposes with genome synthesis technology; research and development relating to genome synthesis technology; technical advisory services and information technology consulting services relating to genome synthesis technology; research and development, quality control for others, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells, all with genome synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems, all with genome synthesis technology; scientific research in the fields of genetics and genetic engineering with genome synthesis technology; testing, inspection and research of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; information technology services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; testing, inspection and research relating to medical treatment or medical technology with genome synthesis technology; information technology consulting services for testing, inspection or research relating to medical treatment or medical technology with genome synthesis technology; testing and research relating to genome or gene to which genome synthesis technology is applied; research and development for the pharmaceutical industry and biotechnology industry with genome synthesis technology; research and development relating to biotechnology for others; research and development relating to genome synthesis technology for others; biotechnology research; research and development in the fields of genomics and biotechnology; technical advisory services in the fields of genomics and biotechnology; structural and functional analysis of genomes; testing, inspection or research on agriculture, livestock breeding or fisheries; development of pharmaceutical preparations and medicines; product development for others; research and development of new products for others; development of new technology for others in the fields of genomics and biotechnology; research and development of genome synthesis technology for others; research and development of new products for others with DNA synthesis technology; DNA synthesis services for others for scientific research purposes; research and development services in the field of gene expression systems; research and development services in the fields of microorganisms and cells; DNA sequence design services for scientific research purposes; research and development of microorganisms for others; research and development of microorganisms which produce useful substances for others; technical research in the field of microorganisms; bacteriological research; biological research
Owner
Prosecution history
- 30 Jul 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 20 Apr 2022 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 21 Mar 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 02 Mar 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 02 Mar 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 05 Feb 2022 — LIMITATION OF GOODS RECEIVED FROM IB
- 10 May 2021 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 21 Apr 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 21 Apr 2021 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 03 Mar 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 02 Mar 2021 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 02 Mar 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 18 Sept 2020 — REFUSAL PROCESSED BY IB
- 17 Aug 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Aug 2020 — NON-FINAL ACTION E-MAILED